Missing/wrong data?
Log in to edit
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.
scientific article published on 29 April 2015
Author/s
author: Owen Tan, Louis Chesler, Michelle Haber, Maria Kavallaris, Selina Sutton, Sela T Po'uha, Belamy B Cheung, Jessica Koach
Work details
Publication date
April 29, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.